FindTrial
Sign In

Comparison of analgesic effect of clonidine with Ropivacaine in paravertebral block for Breast surgery

Comparison of analgesic effect of clonidine as adjuvent with different concentration of Ropivacaine(0.2% and 0.35%) in USG guided thoracic paravertebral block in modified radical Mastectomy: A Prospective Randomized Double Blind Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020406
Enrollment
120
Registered
2019-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C501- Malignant neoplasm of central portion of breast Health Condition 2: C503- Malignant neoplasm of lower-innerquadrant of breast Health Condition 3: C502- Malignant neoplasm of upper-innerquadrant of breast Health Condition 4: C504- Malignant neoplasm of upper-outerquadrant of breast

Interventions

Intervention1: Paravertebral block: Single shot Paravertebral block in patient undergoing MRM surgery Control Intervention1: Ropivacaine and clonidine: Ropivacaine 0.35% (19ml) with normal saline (1ml

Sponsors

Maharana Bhupal Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE 1 OR 2

Exclusion criteria

Exclusion criteria: ASA grade 3 or 4, allergic to study drug, coagulation disorder, cardiovascular disease history, pregnancy

Design outcomes

Primary

MeasureTime frame
Duration of analgesiaTimepoint: 24 hrs postoperatively—

Secondary

MeasureTime frame
Adverse effects related to procedure and drugTimepoint: 24 hrs postoperatively—

Countries

India

Contacts

Public ContactDr Pooja Jain

RNT Medical College Udaipur

drlalitkumar@hotmail.com9414352823

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026